Stock listing

Valirx Plc

Selected listing: A2P1SH · LSX · EUR · DE

Valirx Plc (LS Exchange: A2P1SH), Health Technology. Latest release Sep 15, 2026: Half-year Financial Report.

A2P1SH:LSXEURDEUpdated October 2, 2026
Valirx Plc logo
Ticker
LS Exchange: A2P1SH
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LS Exchange
Currency
EUR

About Valirx Plc

The company focuses on developing innovative therapies for cancer treatment. Valirx is committed to advancing its research and development efforts to address unmet medical needs in oncology.

Latest news from Valirx Plc

Half-year Financial Report

September 15, 2026

Cytolytix Patent Update

August 10, 2026

Result of AGM, Warrants & Directorate Change

July 17, 2026

Conclusion of Evaluation with University of Dundee

June 22, 2026

Conclusion of Evaluation with Stingray

June 2, 2026

All Valirx Plc news →

Events

Replays

  • VALIRX PLC (VAL) — Investor update presentation

    Tue, Sep 28, 2021 · 08:00 AM ET

    Watch

Research Valirx Plc

Valirx Plc company profile

View the public company page for Valirx Plc on 6ix.

Valirx Plc news

Read company news and market updates connected to Valirx Plc.

Valirx Plc investor events

Find investor webinars, events, and replay context for Valirx Plc.

Alternate listings

VAL:LSE

GB · GBX

Alternate listing for Valirx Plc; the primary context on this page is A2P1SH:LSX.

A2P1SH:LS

DE · EUR

Alternate listing for Valirx Plc; the primary context on this page is A2P1SH:LSX.

EAJF:FWB

DE · EUR

Alternate listing for Valirx Plc; the primary context on this page is A2P1SH:LSX.

EAJF:SWB

DE · EUR

Alternate listing for Valirx Plc; the primary context on this page is A2P1SH:LSX.